2Blackburn AM, Christotides ND, Ghatei MA. Elevation of plasma neurotensin in the dumping syndrome. Clin Sci, 1980,59:237-243.
3Preston DM, Adrian TE, Christotides ND, et al. Postive correlation between symptoms and circulating motilin, pancreatic polypeptide and gastrin level in functional bowel disease. Gut,1985,26:1059-1064.
4Camilleri M. Effects of somatostatin analogues on human gastrointestinal motility. Digestion, 1996, 57: suppl 1:90-92.
5Huizinga JD, Thuneberg L, Kluppel M, et al. W/kit gene required for interstitial cells of Cajal and for intestinal pacemaker activity. Nature, 1995, 373:347-349.
6Hagger R, Finlayson C, Jeffrey I, et al. Role of the inter-stitial cells of Cajal in the control of gut motility. Br J Surg,1997,84:445-450.
7Huizinga JD, Thuneberg L, Vanderwinden JM, et al.Interstitial cells of Cajal as tagets for pharmacological intervention in gastrointestinal motor disorders. Thends Pharmacol Sci,1997, 18:393-403.
8Gregory PC. Gastrointestinal pH, motility/transient and permeability in cystic fibrosis.J Pediatr Gastroenterol Nutr,1996, 23:513-523.
9Young MA, Rose S, Reynolds JC. Gastrointestinal manifestations of scleroderma. Rheum Dis Clin North Am, 1996,22:797-823.
10Jost WH. Gastrointestinal motility problems in patients with Parkinson's disease. Effects of antiparkinsonian treatment and guidelines for management. Drugs Aging, 1997,10:249-258.
